Isan Chen, M.D.

Isan Chen, M.D.

DirectoratTyra Biosciences· In proxies 2023–2024

Isan Chen, M.D. sits on 1 public board.

Boards1

  • Tyra BiosciencesDirector · 3 yr on the boardIndependentCompensation—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Tyra BiosciencesPublic company · 3 yr
    • Director2023 – Present · 3 yrStock in role +154%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?